Accretive Health Reports Inducement Grant

Accretive Health, Inc. (OTC Pink: ACHI) today announced that, in connection with the appointment of David Mason as the company’s chief strategy officer, on November 11, 2014, Accretive Health granted to Mason a nonstatutory stock option and shares of restricted common stock (collectively the “Inducement Grants”) as an inducement material to Mason’s acceptance of employment with the company.

The stock option is for the purchase of 400,000 shares of the company’s common stock, with an exercise price of $7.15, which was the closing price of the company’s common stock reported through the facilities of the OTC Markets Group Inc. on November 11, 2014. The restricted stock award was a grant of 300,000 shares of restricted common stock of the company. The Inducement Grants generally will vest in equal annual installments over four years following the grant date, subject to continued service with the company. The Inducement Grants were approved by the company’s Board of Directors and will be issued outside of the company’s 2010 Stock Incentive Plan.

About Accretive Health

At Accretive Health, our mission is to partner with healthcare communities to serve as a catalyst for a healthier future for all. For more information, visit www.accretivehealth.com.